Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,661 across all filing types
Latest filing 2020-12-28 Regulatory Filings
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Morepen Laboratories Ltd has informed BSE regarding loss of share Certificates of the Company
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (National Stock Exchange of India Ltd. and Bombay Stock Exchange Limited) regarding the loss of share certificates by shareholders and the request for issuance of duplicate share certificates. It references Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to reporting such events. The document contains multiple letters from the Registrar and Share Transfer Agent detailing specific lost share certificates and shareholders' names. There is no financial data, earnings information, management discussion, or report publication mentioned. The content is an official notification to the stock exchanges about share certificate loss incidents, which is a regulatory disclosure but does not fit into categories like Annual Report, Earnings Release, or Capital/Financing Update. It is not a report itself but a regulatory announcement. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-12-28 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the issuance of duplicate share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management. The content is about notifying the exchange of a corporate action related to share certificates, not a financial report, earnings release, or management discussion. It is a regulatory announcement about share certificate issuance, which fits best under Regulatory Filings (RNS) as it does not fit other specific categories like Share Issue/Capital Change (SHA) or Transaction in Own Shares (POS). The document length is short and it is an official notification letter, not a report or presentation.
2020-12-22 English
Morepen Laboratories Ltd has informed BSE regarding issuance of duplicate share Certificate by the Company
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the issuance of duplicate share certificates. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 39(3). The content is about administrative action related to share certificates, not financial results, management changes, or other report types. The document length is short (2941 characters) and it is an announcement of a corporate action (duplicate share certificate issuance). This fits best under Regulatory Filings (RNS) as it is a regulatory disclosure that does not fit other specific categories like share issue or director dealings.
2020-12-22 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the loss of share certificates, referencing Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements). It is an intimation or notification about a specific event related to share certificates, not a financial report, earnings release, or management discussion. The document length is short (1494 characters), and it serves as a regulatory notification to exchanges. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-12-18 English
Morepen Laboratories Ltd has informed BSE regarding loss of share Certificates of the Company
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the loss of share certificates by a shareholder and the request for issuance of duplicate share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The content is an official notification about a shareholder's lost share certificates and does not contain financial data, management discussion, or report content. It is not an annual report, earnings release, or any financial report. It is also not a director dealing or shareholding notification about ownership thresholds. The document is a regulatory announcement related to compliance and shareholder records. Given the nature and length (2604 characters), it is not a report publication announcement but a regulatory filing. Therefore, the best classification is Regulatory Filings (RNS).
2020-12-18 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the issuance of duplicate share certificates. It references compliance with SEBI regulations and includes details about the duplicate certificates issued. The content is an official notification about a specific corporate action related to share certificates, not a financial report, earnings release, or management discussion. It is not a report publication announcement or a certification. The document fits best under the category of Regulatory Filings (RNS) as it is a regulatory announcement about share certificate issuance and does not fit other more specific categories like Share Issue/Capital Change (SHA) because it concerns duplicate certificates, not new share issuance or capital changes.
2020-12-15 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.